Browsing Other ICR Research by author "Chowdhury, Avirup"

Now showing items 1-1 of 1

    • Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis. 

      Claudiani, S; Mason, CC; Milojkovic, D; Bianchi, A; Pellegrini, C; et al. (MDPI, 2021-09-28)
      As the first FDA-approved tyrosine kinase inhibitor for treatment of patients with myelofibrosis (MF), ruxolitinib improves clinical symptoms but does not lead to eradication of the disease or significant reduction of the ...